By critically analyzing both in vivo and in vitro studies, we seek to elucidate the molecular mechanisms through which OPN influences inflammatory pathways in AD, with a focus on identifying key signaling cascades and their downstream effects. This evidence concerns the gene SPP1 and Alzheimer disease.